CRISM Therapeutics Corporation (CRTX.L)
CRTX.L Stock Price Chart
Explore CRISM Therapeutics Corporation interactive price chart. Choose custom timeframes to analyze CRTX.L price movements and trends.
CRTX.L Company Profile
Discover essential business fundamentals and corporate details for CRISM Therapeutics Corporation (CRTX.L) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Biotechnology
IPO Date
17 Oct 2003
Employees
4.00
CEO
Robin Jay Young
Description
CRISM Therapeutics Corporation focuses on drug delivery technology to improve the clinical performance of cancer drugs as treatments for solid tumors. Its lead product, ChemoSeed that can be implanted directly into a tumor or the resection margin following the removal of a tumor, ensuring effective therapeutic concentrations of chemotherapy drugs directly reach the tumor tissue. Its ChemoSeed used for treatment of gliomas, a brain tumor. The company was founded in 2016 and is based in Road Town, the British Virgin Islands.
CRTX.L Financial Timeline
Browse a chronological timeline of CRISM Therapeutics Corporation corporate events including earnings releases, dividend announcements, and stock splits.
Earnings released on 9 May 2025
Earnings released on 19 Sept 2024
EPS came in at -£0.00 .
Stock split effective on 31 May 2024
Shares were split 1 : 160 , changing the number of shares outstanding and the price per share accordingly.
Earnings released on 10 May 2024
EPS came in at -£0.05 .
Earnings released on 29 Jun 2023
EPS came in at -£0.26 .
Dividend declared on 1 Jun 2023
A dividend of £1.80 per share was announced, adjusted to £288.00. The dividend was paid on 14 Jun 2023.
Earnings released on 30 Dec 2022
EPS came in at -£0.13 .
Earnings released on 29 Jun 2022
EPS came in at -£0.21 .
Earnings released on 30 Dec 2021
EPS came in at -£0.27 .
Earnings released on 29 Jun 2021
EPS came in at £0.03 .
Earnings released on 30 Dec 2020
EPS came in at -£0.14 .
CRTX.L Stock Performance
Access detailed CRTX.L performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.